Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
about
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.A studentized permutation test for three-arm trials in the 'gold standard' design.Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.
P2860
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@ast
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@en
type
label
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@ast
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@en
prefLabel
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@ast
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@en
P2860
P1433
P1476
Changing EDSS Progression in P ...... ic Review and Meta-Regression.
@en
P2093
Richard Nicholas
Sebastian Straube
P2860
P304
P356
10.1371/JOURNAL.PONE.0137052
P407
P577
2015-09-01T00:00:00Z